Adjunctive Chinese medicine therapy reduces relapse of psoriasis vulgaris after discontinuation of biologics: a prospective registry-based cohort study

References

• National Psoriasis Foundation. Psoriasis Statistics. [accessed 2023 Dec 8]. Available from: https://www.psoriasis.org/content/statistics.
   Google Scholar
• Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis a review. JAMA-J Am Med Assoc. 2020;323(19):1–9. doi: 10.1001/jama.2020.4006.
   Web of Science ®Google Scholar
• Chen Y, Wei L, Song Y, et al. Life quality among psoriasis patients based on dermatology life quality index evaluation and its association with psoriasis severity in China: a cross-sectional study. Ann Med. 2023;55(1):2231847.
   PubMed Web of Science ®Google Scholar
• Sbidian E, Chaimani A, Garcia-Doval I, et al. Systemic phar­macological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database Syst Rev. 2022;5(5):cd011535.
   PubMedGoogle Scholar
• Huang S, Bai Y. Knowledge mapping and research hotspots of comorbidities in psoriasis: a bibliometric analysis from 2004 to 2022. Medicina. 2023;59(2):393. doi: 10.3390/medicina59020393.
   Google Scholar
• Scala E, Kaczmarczyk R, Zink A, et al. Sociodemographic, clinical and therapeutic factors as predictors of life quality impairment in psoriasis: a cross-sectional study in Italy. Dermatol Ther. 2022;35(8):e15622.
   PubMed Web of Science ®Google Scholar
• Wang XY, Zhang CL, Wang WH. Time to relapse after treatment withdrawal for different biologics used to treat plaque psoriasis. Chin Med J (Engl). 2020;133(24):2998–3000. doi: 10.1097/CM9.0000000000001232.
   PubMed Web of Science ®Google Scholar
• Masson Regnault M, Shourick J, Jendoubi F, et al. Time to relapse after discontinuing systemic treatment for psoriasis: a systematic review. Am J Clin Dermatol. 2022;23(4):433–447. doi: 10.1007/s40257-022-00679-y.
   PubMed Web of Science ®Google Scholar
• Owczarek W, Dzik M, Narbutt J, et al. Real-world evidence on time to relapse of plaque psoriasis after discontinuation of biologic treatment in Poland. Dermatol Ther. 2021;34(5):e15052.
   PubMed Web of Science ®Google Scholar
• Chiu HY, Hui RC, Tsai TF, et al. Predictors of time to relapse following ustekinumab withdrawal in patients with psoriasis who had responded to therapy: an 8-year multicenter study. J Am Acad Dermatol. 2023;88(1):71–78.
   PubMed Web of Science ®Google Scholar
• van den Reek J, Tummers M, Zweegers J, et al. Predictors of adalimumab drug survival in psoriasis differ by reason for discontinuation: long-term results from the Bio-CAPTURE registry. J Eur Acad Dermatol Venereol. 2015;29(3):560–565. doi: 10.1111/jdv.12636.
   PubMed Web of Science ®Google Scholar
• Li Y, Lu JJ, Zhong XY, et al. Drug survival outcomes associated with the real-world use of ixekizumab, secukinumab, guselkumab, and adalimumab for the treatment of plaque psoriasis in China: a 52-week single-center retrospective study. Clin Cosmet Investig Dermatol. 2022;15:2245–2252.
   PubMed Web of Science ®Google Scholar
• Yang XY, Cai WL, Guo CL, et al. Chinese medicine as supporting therapy for psoriasis: past, present, and future. Chin J Integr Med. 2023;29(3):280–288.
   PubMed Web of Science ®Google Scholar
• Li T, Gao S, Han W, et al. Potential effects and mechanisms of Chinese herbal medicine in the treatment of psoriasis. J Ethnopharmacol. 2022;294:115275.
   PubMed Web of Science ®Google Scholar
• Li M, Hu X, Hao PS. Research “recover from illness defense complex” helper T cell immune mechanisms based on the “fuxie” theory clearing away heat evil thoroughly nourishing kidney treatment of recurrent blood-heat syndrome psoriasis. Medicine. 2020;99(20):e20161. doi: 10.1097/MD.0000000000020161.
   PubMed Web of Science ®Google Scholar
• Yao DN, Lu CJ, Wen ZH, et al. Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial. Trials. 2016;17(1):140. doi: 10.1186/s13063-016-1272-x.
   PubMedGoogle Scholar
• Chen Y, Yan Y, Liu H, et al. Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8(+) T-cell memory in wild-type and humanized mice. Theranostics. 2020;10(23):10466–10482. doi: 10.7150/thno.45211.
   PubMed Web of Science ®Google Scholar
• Xu WJ, Zhang NL, Li P, et al. Applying latent tree analysis to classify traditional Chinese medicine syndromes (Zheng) in patients with psoriasis vulgari. J Tradit Chin Med. 2022;42(1):132–139.
   PubMed Web of Science ®Google Scholar
• Harris KM, Smilek DE, Byron M, et al. Effect of costimulatory blockade with abatacept after ustekinumab withdrawal in patients with moderate to severe plaque psoriasis: the PAUSE randomized clinical trial. JAMA Dermatol. 2021;157(11):1306–1315. doi: 10.1001/jamadermatol.2021.3492.
   PubMed Web of Science ®Google Scholar
• Carmona-Rocha E, Puig L. The biological basis of disease recurrence in psoriasis. Ital J Dermatol Venerol. 2023;158(4):279–291. doi: 10.23736/S2784-8671.23.07583-7.
   PubMedGoogle Scholar
• Benezeder T, Wolf P. Resolution of plaque-type psoriasis: what is left behind (and reinitiates the disease). Semin Immunopathol. 2019;41(6):633–644. doi: 10.1007/s00281-019-00766-z.
   PubMed Web of Science ®Google Scholar
• Puig L, Costanzo A, Muñoz-Elías EJ, et al. The biological basis of disease recurrence in psoriasis: a historical perspective and current models. Br J Dermatol. 2022;186(5):773–781. doi: 10.1111/bjd.20963.
   PubMed Web of Science ®Google Scholar
• Wang G, Bai F, Tian Z, et al. Balneotherapy with Chinese herbal medicine prolongs the remission period in patients with psoriasis vulgaris. Dermatol Ther. 2020;33(3):e13351. doi: 10.1111/dth.13351.
   PubMed Web of Science ®Google Scholar
• Guan J, Yuan S, Wu H, et al. Effectiveness and safety of traditional Chinese medical bath therapy combined with ultraviolet irradiation in the treatment of psoriasis: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2017;12(3):e0173276. doi: 10.1371/journal.pone.0173276.
   PubMed Web of Science ®Google Scholar
• Liu N, Qin H, Cai Y, et al. Dynamic trafficking patterns of IL-17-producing γδ T cells are linked to the recurrence of skin inflammation in psoriasis-like dermatitis. EBioMedicine. 2022;82:104136. doi: 10.1016/j.ebiom.2022.104136.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li X, Chen Y, et al. Xiao-Yin-Fang therapy alleviates psoriasis-like skin inflammation through suppressing γδT17 cell polarization. Front Pharmacol. 2021;12:629513. doi: 10.3389/fphar.2021.629513.
   PubMed Web of Science ®Google Scholar
• Sun Y, Zhang J, Zhou Z, et al. CCN1, a pro-inflammatory factor, aggravates psoriasis skin lesions by promoting keratinocyte activation. J Invest Dermatol. 2015;135(11):2666–2675.
   PubMed Web of Science ®Google Scholar
• Guo WJ, Wang Y, Deng Y, et al. Therapeutic effects of the extract of Sancao Formula, a Chinese herbal compound, on imiquimod-induced psoriasis via cysteine-rich protein 61. J Integr Med. 2022;20(4):376–384.
   PubMedGoogle Scholar
• Watson N, Wilson N, Shmarov F, et al. The use of psoriasis biomarkers, including trajectory of clinical response, to predict clearance and remission duration to UVB phototherapy. J Eur Acad Dermatol Venereol. 2021;35(11):2250–2258. doi: 10.1111/jdv.17519.
   PubMed Web of Science ®Google Scholar
• Kurihara K, Fujiyama T, Phadungsaksawasdi P, et al. Significance of IL-17A-producing CD8 + CD103+ skin resident memory T cells in psoriasis lesion and their possible relationship to clinical course. J Dermatol Sci. 2019;95(1):21–27. doi: 10.1016/j.jdermsci.2019.06.002.
   PubMed Web of Science ®Google Scholar
• Eyerich K, Weisenseel P, Pinter A, et al. IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants with moderate-to-severe plaque-type psoriasis (GUIDE). BMJ Open. 2021;11(9):e049822. doi: 10.1136/bmjopen-2021-049822.
   PubMed Web of Science ®Google Scholar